Claris Lifesciences sells its stake in JV to Otsuka Pharmaceutical Factory

21 Sep 2017 Evaluate

Claris Lifesciences has completed the sale of its remaining 20% stake in Otsuka Pharmaceutical India, the joint venture with Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co., to Otsuka Pharmaceutical Factory, Inc. (Japan) for a consideration of $20 million. The agreement to sell was announced on May 8, 2017.

Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology.

Peers
Company Name CMP
Redington 271.15
Adani Enterprises 2231.85
Amrapali Industries 14.81
Rashi Peripheral 357.00
PDS 366.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×